Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0310
-0.0010 (-3.13%)
At close: Feb 13, 2026
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 173.25 million as of February 13, 2026. Its market cap has increased by 6.90% in one year.
Market Cap
173.25M
Enterprise Value
266.70M
Revenue
891.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 173.25M, a decrease of -75.92%. That is a compound annual growth rate of -9.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 173.25M | 6.90% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 639.06M |
| China NT Pharma Group Company | 505.68M |
| Wai Yuen Tong Medicine Holdings | 399.41M |
| Regent Pacific Group | 294.73M |
| Shenzhen Neptunus Interlong Bio-technique Company | 266.80M |
| Tianda Pharmaceuticals | 221.45M |
| Extrawell Pharmaceutical Holdings | 201.45M |
| Joyzyme Group | 185.57M |